Sopharma AD-Sofia (WAR:SPH) E10: zł1.24 (As of Mar. 2026)


WAR:SPH Sopharma AD-Sofia WAR:SPH
67 GF Score
Price zł7.92
GF Value zł13.56
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Sopharma AD-Sofia E10?

Sopharma AD-Sofia WAR:SPH 67 E10 is zł1.24 as of Mar. 2026. GuruFocus rates WAR:SPH with a GF Score™ of 67/100 and a GF Value™ of zł13.56 (Possible Value Trap). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Sopharma AD-Sofia's adjusted earnings per share data for the three months ended in Mar. 2026 was zł0.255. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is zł1.24 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average E10 Growth Rate was 5.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Sopharma AD-Sofia was 5.50% per year. The lowest was 5.50% per year. And the median was 5.50% per year.

As of today (2026-06-27), Sopharma AD-Sofia's current stock price is zł7.92. Sopharma AD-Sofia's E10 for the quarter that ended in Mar. 2026 was zł1.24. Sopharma AD-Sofia's Shiller PE Ratio of today is 6.39.

During the past 13 years, the highest Shiller PE Ratio of Sopharma AD-Sofia was 30.42. The lowest was 5.91. And the median was 20.74.


Sopharma AD-Sofia  (WAR:SPH) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Sopharma AD-Sofia's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=7.92/1.24
=6.39

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Sopharma AD-Sofia was 30.42. The lowest was 5.91. And the median was 20.74.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Sopharma AD-Sofia E10 Related Terms


Sopharma AD-Sofia E10 Historical Data

* Premium members only.

The historical data trend for Sopharma AD-Sofia's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sopharma AD-Sofia E10 Chart

Sopharma AD-Sofia Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.54 0.47 0.62 0.57 1.23

Sopharma AD-Sofia Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.58 1.26 1.23 1.24

WAR:SPH vs MCK, COR, CAH: E10 Comparison

For the Medical Distribution subindustry, Sopharma AD-Sofia's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sopharma AD-Sofia Shiller PE Ratio vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sopharma AD-Sofia's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Sopharma AD-Sofia's Shiller PE Ratio falls into.


WAR:SPH
67GF Score
Sopharma AD-Sofia WAR:SPH
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sopharma AD-Sofia E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Sopharma AD-Sofia's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.255/330.2130*330.2130
=0.255

Current CPI (Mar. 2026) = 330.2130.

Sopharma AD-Sofia Quarterly Data

per share eps CPI Adj_EPS
201603 0.168 238.132 0.233
201606 0.258 241.018 0.353
201609 0.086 241.428 0.118
201612 0.295 241.432 0.403
201703 0.264 243.801 0.358
201706 0.194 244.955 0.262
201709 0.067 246.819 0.090
201712 -0.202 246.524 -0.271
201803 0.225 249.554 0.298
201806 0.147 251.989 0.193
201809 0.108 252.439 0.141
201812 0.023 251.233 0.030
201903 0.529 254.202 0.687
201906 0.121 256.143 0.156
201909 0.182 256.759 0.234
201912 0.881 256.974 1.132
202006 0.000 257.797 0.000
202009 0.022 260.280 0.028
202012 0.144 260.474 0.183
202103 0.312 264.877 0.389
202106 0.252 271.696 0.306
202109 0.314 274.310 0.378
202112 0.651 278.802 0.771
202203 0.350 287.504 0.402
202206 0.376 296.311 0.419
202209 0.369 296.808 0.411
202212 0.015 296.797 0.017
202303 0.521 301.836 0.570
202306 0.507 305.109 0.549
202309 0.179 307.789 0.192
202312 0.183 306.746 0.197
202403 0.468 312.332 0.495
202406 0.196 314.175 0.206
202409 0.167 315.301 0.175
202412 0.137 315.605 0.143
202503 0.000 319.799 0.000
202506 0.378 322.561 0.387
202509 0.171 324.800 0.174
202512 0.077 324.054 0.078
202603 0.255 330.213 0.255

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of zł1.24 mean?
Sopharma AD-Sofia (WAR:SPH) has a E10 of zł1.24 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Sopharma AD-Sofia and its competitors.
Is Sopharma AD-Sofia's E10 too high?
Sopharma AD-Sofia's current E10 is zł1.24. Overall, Sopharma AD-Sofia has a GF Score™ of 67/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Sopharma AD-Sofia's E10 compare to MCK and COR?
Sopharma AD-Sofia's E10 of zł1.24 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Medical Distribution company?
A good E10 depends on the Medical Distribution industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Sopharma AD-Sofia and its competitors. Sopharma AD-Sofia's current E10 is zł1.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sopharma AD-Sofia stock overvalued right now?
Based on GuruFocus' analysis, Sopharma AD-Sofia (WAR:SPH) is currently considered Possible Value Trap. The stock's GF Value™ is zł13.56, compared to a current price of zł7.92 — trading 41.6% below its estimated fair value. The current E10 is zł1.24. Sopharma AD-Sofia's overall GF Score™ is 67/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Sopharma AD-Sofia (WAR:SPH), the current E10 is zł1.24 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sopharma AD-Sofia (WAR:SPH) Overvalued in 2026?

Based on GuruFocus' analysis, Sopharma AD-Sofia stock appears to be undervalued. The current stock price of zł7.92 is trading 41.6% below its estimated GF Value™ of zł13.56. GuruFocus considers Sopharma AD-Sofia to be Possible Value Trap.

Key valuation signals for WAR:SPH:

  • E10: zł1.24
  • GF Value™: zł13.56 vs. price of zł7.92 (41.6% below fair value)
  • GF Score™: 67/100 with 3 warning signs

No single metric tells the full story. See the WAR:SPH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sopharma AD-Sofia Business Description

Other Exchanges 3JR:GermanySFA:Bulgaria
Address 5 Lachezar Stanchev Street, Sopharma Business Towers, Building A, Floor 12, Sofia, BGR, 1756
Sopharma AD-Sofia is a company engaged in the production of pharmaceutical products. Its principal activities include the production and trade of medicinal substances and finished drug forms; and research and development as well as engineering and implementation activities in the field of medicinal products. It is also focused on the distribution of pharmaceuticals like medical supplies, sanitary materials, vitamins, food supplements, and cosmetics. The company's segments are the Production of pharmaceutical products; Distribution of pharmaceutical products. It generates the majority of its revenue from the Distribution of pharmaceutical products.
67GF Score

Get the complete analysis for WAR:SPH

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł7.92
Price
zł13.56
GF Value